John Wiley & Sons Abnormal Chromosomes Cover Explore the past, present, and future of cancer cytogenetics In Abnormal Chromosomes: The Past, Pre.. Product #: 978-1-119-65198-7 Regular price: $120.56 $120.56 In Stock

Abnormal Chromosomes

The Past, Present, and Future of Cancer Cytogenetics

Heim, Sverre / Mitelman, Felix


1. Edition March 2022
208 Pages, Hardcover
Wiley & Sons Ltd

ISBN: 978-1-119-65198-7
John Wiley & Sons

Buy now

Price: 129,00 €

Price incl. VAT, excl. Shipping

Further versions


Explore the past, present, and future of cancer cytogenetics

In Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics, globally renowned researchers Drs. Sverre Heim and Felix Mitelman deliver a state-of-the-art review of how cancer cytogenetic analyses have contributed to an improved understanding of tumorigenesis as well as to the diagnosis and treatment of cancer patients. The book also discusses how cytogenetics - the study of chromosomes - meets, interacts with, and cross-fertilizes other investigative technologies, including molecular somatic cell genetics.

The book provides an impetus to think more deeply about the role chromosomes, and their abnormalities, play in health and disease, especially in neoplastic disorders. From which origins did cytogenetics develop? How did the finding of acquired chromosomal abnormalities in cells of leukemias and solid tumors influence our understanding of cancer as a biological process? How was information of this nature put to good use in the clinical management of cancer patients?

Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics offers readers:
* A thorough introduction to ancient theories of disease, the advent of cellular pathology, and how a scientific interest in chromosomes developed
* Comprehensive exploration of the conceptual importance of Theodor Boveri and his somatic mutation theory of cancer
* A detailed chronological resume of cancer cytogenetic discoveries during the 20th century
* In-depth discussions of the role of chromosome abnormalities, oncogenes, and tumor suppressor genes in leukemias, lymphomas, and solid tumors, together with a survey of what chromosome analyses have revealed about the clonal evolution of neoplastic cell populations
* A discussion of the importance of pathogenetic classifications of neoplastic diseases, the role chromosome abnormalities play in this context, and which technological breakthroughs can be expected in chromosome-oriented cancer research
Abnormal Chromosomes: The Past, Present, and Future of Cancer Cytogenetics was written for everyone with a scientific or clinical interest in cancer, especially how acquired chromosome abnormalities lead to neoplastic transformation. The book teaches how cytogenetic analyses contribute to a better understanding of tumorigenesis, but also how the finding of specific chromosome aberrations can be crucial for the diagnosis, prognosis, and management of cancer patients.

Preface vii

Part I Past 1

Chapter 1 Understanding Disease: Ancient Theories 3

Chapter 2 The Advent of Cellular Pathology 7

Chapter 3 The Colored Bodies of Cell Nuclei: Chromosomes and Heredity 15

Chapter 4 Boveri and the Somatic Mutation Theory of Cancer 23

Chapter 5 Cytogenetics from 1914 to 1960: Slow Progress Followed by Serendipitous Methodological Breakthroughs Leading to Important Discoveries 29

Chapter 6 The First Cancer-Specific Chromosome Aberrations: Ph1 and Others 41

Part II Present 57

Chapter 7 The Banding Revolution: Cancer Cytogenetics in the 1970s 59

Chapter 8 Chasing Correlations: Chromosomes and Oncogenes in Leukemias and Lymphomas 75

Chapter 9 Solid Tumor Cytogenetics 87

Chapter 10 Gains, Losses, and Rearrangements of Genomic Material: Pathogenetic Considerations 105

Chapter 11 Morphology Meets Chemistry: Integration of Molecular Genetics into the Cytogenetic Search for Cancer-Specific Chromosome Aberrations 117

Chapter 12 Unraveling the Clonal Evolution of Neoplastic Cell Populations 125

Chapter 13 Clinical Usefulness 137

Part III Future 149

Chapter 14 Toward a Pathogenetic Classification of Cancer 151

Chapter 15 Where There is Structure, There is Function 161

Chapter 16 Which Resolution Level is Optimally Suited to

Answer Which Questions? Seeing Never Goes Out of Fashion . . . 169

Chapter 17 Are New Technical Breakthroughs on the Horizon? 179

Afterthoughts 189

Index 195
Sverre Heim has over thirty years' experience in the field of cancer cytogenetics. He has used chromosomal markers to trace the clonal relationships among neoplastic cell populations and determined their patterns of evolution. He has served on editorial boards and scientific advisory committees and authored nearly 500 scientific publications.

Felix Mitelman is an elected member of the Royal Swedish Academy of Sciences and the American Academy of Arts and Sciences, as well as the Editor-in-Chief and Founder of Genes, Chromosomes & Cancer.

S. Heim, The Norwegian Radium Hospital, Norway; F. Mitelman, University of Lund, Sweden